CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 5.46 HKD -1.97%
Market Cap: HK$8.1B

Intrinsic Value

The intrinsic value of one CStone Pharmaceuticals stock under the Base Case scenario is 1.07 HKD. Compared to the current market price of 5.46 HKD, CStone Pharmaceuticals is Overvalued by 80%.

Intrinsic Value
1.07 HKD
Overvaluation 80%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
CStone Pharmaceuticals

What is Valuation History?
Ask AI Assistant
What other research platforms think about CStone Pharmaceuticals?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CStone Pharmaceuticals valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for CStone Pharmaceuticals.

Explain Valuation
Compare CStone Pharmaceuticals to
Custom
Choose any stock to compare

Fundamental Analysis

Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
profitability
Score

Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
solvency
Score
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CStone Pharmaceuticals?
Bearish
Neutral
Bullish
Financials
Efficiency

Free Cash Flow Analysis
CStone Pharmaceuticals

Last Value
3-Years Average
FCF Margin
Conversion Rate

Wall St
Price Targets

Price Targets Summary
CStone Pharmaceuticals

Wall Street analysts forecast CStone Pharmaceuticals stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CStone Pharmaceuticals is 13.93 HKD with a low forecast of 7.38 HKD and a high forecast of 21 HKD.

Lowest
Price Target
7.38 HKD
35% Upside
Average
Price Target
13.93 HKD
155% Upside
Highest
Price Target
21 HKD
285% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

CStone Pharmaceuticals
does not pay dividends
Shareholder Yield

Current shareholder yield for CStone Pharmaceuticals is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CStone Pharmaceuticals stock?

The intrinsic value of one CStone Pharmaceuticals stock under the Base Case scenario is 1.07 HKD.

Is CStone Pharmaceuticals stock undervalued or overvalued?

Compared to the current market price of 5.46 HKD, CStone Pharmaceuticals is Overvalued by 80%.

Back to Top